EPIDAREX CAPITAL PARTNERS LIMITED - Profile & Financials

Accounts Submitted 3 Oct 2025

Confirmation Statement Submitted 11 Dec 2025

Net assets £-2.00 £0.00 2024 year on year

Total assets £0.00

Total Liabilities £2.00

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

137a George Street Edinburgh EH2 4JY Scotland

Credit Report

Discover EPIDAREX CAPITAL PARTNERS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

N/A

Net Assets

-£2.00

Total Liabilities

£2.00

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

4 active

Show resigned officers

						Status
Andrew Sinclair Dunlop	Director	British	United Kingdom	53	30 Nov 2012	Active
Elizabeth Roper	Director	Irish	United Kingdom	51	1 Oct 2013	Active
Kyparissia Katie Sirinakis	Director	American	America	60	30 Nov 2012	Active
Peter Michael Finan	Director	British	England	58	17 Jun 2019	Active

Shareholders

Shareholders (1)


Epidarex Management Limited	100.0%	2	Ordinary	14 Dec 2020

Persons with Significant Control

Persons with Significant Control (1)

1 Active 4 Ceased

Epidarex Management Ltd

United Kingdom

Active

Notified 27 Jan 2020

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

Andrew Sinclair Dunlop

Ceased 17 Jun 2019

Ceased

Kyparissia Katie Sirinakis

Ceased 17 Jun 2019

Ceased

Elizabeth Ann Roper

Ceased 17 Jun 2019

Ceased

Peter Michael Finan

Ceased 17 Jun 2019

Ceased

See All Controllers

Group Structure

EPIDAREX MANAGEMENT LTD united kingdom

EPIDAREX CAPITAL PARTNERS LIMITED Current Company

ADORX THERAPEUTICS LIMITED united kingdom shares 50 to 75 percent, voting rights 50 to 75 percent, appoint/remove directors

EPIDAREX CAPITAL II GP, LP united kingdom part right to share surplus assets 75 to 100 percent

EPIDAREX CAPITAL III UK GP, LP united kingdom part right to share surplus assets 75 to 100 percent

EPIDAREX CAPITAL UK GP, LLP united kingdom voting rights 25 to 50 percent limited liability partnership, right to share surplus assets 25 to 50 percent limited liability partnership

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
11 Dec 2025	Officers	Change to director Mrs Elizabeth Roper on 2025-12-11	View(2 pages)
11 Dec 2025	Confirmation Statement	Confirmation statement made on 2025-11-30 with no updates	View(3 pages)
3 Oct 2025	Accounts	Annual accounts made up to 2025-03-31	View(9 pages)
11 Dec 2024	Confirmation Statement	Confirmation statement made on 2024-11-30 with no updates	View(3 pages)
10 Dec 2024	Persons With Significant Control	Cessation of Andrew Sinclair Dunlop as a person with significant control on 2019-06-17	View(1 page)